RVNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Investors who lost money on Revance Therapeutics,

Revance Therapeutics, Inc. (NASDAQ:RVNC) Given Consensus Rating of "Hold" by Brokerages

Shareholders that lost money on Revance Therapeutics, Inc.(RVNC) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

DEADLINE ALERT for NXT, RVNC, REGN, BIOA: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

Deadline Alert: Revance Therapeutics, Inc. (RVNC) Investors